FDA Inspection
Willow Birch Pharma, Inc.Willow Birch Pharma, Inc. – FDA Inspection, Oct 28, 2016
Record Details
This FDA Inspection record concerns Willow Birch Pharma, Inc., with an inspection on October 28, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · d5450bf7-e3bc-40c3-a336-d78b3a18e1db
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 991592
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
6- 21 CFR 211.150(b)Recall facilitation
- 21 CFR 211.46(b)Equipment for Environmental Control
- 21 CFR 211.130Procedures are written, and followed
- 21 CFR 211.188(a)Accurate reproduction
- 21 CFR 211.188(b)(7)Actual yield, % of theoretical yield
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Willow Birch Pharma, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 3, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Willow Birch Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.